Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Christopher W. Smith. (2022) Release of α-granule contents during platelet activation. Platelets 33:4, pages 491-502.
Read now
Read now
Jialan Zang, Yong Hu, Xiaoyue Xu, Jie Ni, Dali Yan, Siwen Liu, Jieyu He, Jing Xue, Jianzhong Wu & Jifeng Feng. (2017) Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer. OncoTargets and Therapy 10, pages 409-415.
Read now
Read now
Magdalena Chechlinska, Maria Kowalska & Janina Kaminska. (2008) Cytokines as potential tumour markers. Expert Opinion on Medical Diagnostics 2:6, pages 691-711.
Read now
Read now
David Loven, David Loven, Einat Be'Ery, David Loven, Einat Be'Ery, Rinat Yerushalmi, Claude Koren, Aaron Sulkes, Idit Lavi, Yuval Shaked & Eyal Fenig. (2008) Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients. Acta Oncologica 47:1, pages 104-109.
Read now
Read now
Articles from other publishers (80)
Suleyman ILHAN. (2023) Effect of interleukin-8 on docetaxel resistance in prostate cancer cells: insights into the role of multidrug resistance 1 protein modulation. Cancer Insight.
Crossref
Crossref
Chunhua Xu, Jue Zou, Li Li, Qi Yuan & Wei Wang. (2022)
Elevated serum Cripto‐1 and
VEGF
levels in patients with non‐small cell lung cancer
. FASEB BioAdvances 4:8, pages 539-546.
Crossref
Crossref
Monika Kosacka, Tomasz Dyła, Monika Chaszczewska-Markowska, Katarzyna Bogunia-Kubik & Anna Brzecka. (2021) Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer. Journal of Clinical Medicine 10:17, pages 3859.
Crossref
Crossref
Valentinos Kounnis, Jon Cleland, Faisal Azam, Rachel Midgley & David J. Kerr. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine
195
202
.
Changjiang Liu, Xuetao Zhou, Zefeng Zhang & Yang Guo. (2020) Correlation of gene polymorphisms of vascular endothelial growth factor with grade and prognosis of lung cancer. BMC Medical Genetics 21:1.
Crossref
Crossref
Jennifer Pérez-Boza, Amandine Boeckx, Michele Lion, Franck Dequiedt & Ingrid Struman. (2020) hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells. Cellular and Molecular Life Sciences 77:21, pages 4413-4428.
Crossref
Crossref
Elisabeth Karsten, Edmond Breen, Sharon A. McCracken, Stephen Clarke & Benjamin R. Herbert. (2020) Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function. Scientific Reports 10:1.
Crossref
Crossref
Wei Sun, Guifu He, Mingming Zhang, Yi Zhao, Hongmei Yu, Yi Li, Wei Wu & Tiefeng Ji. (2019)
99m
Tc-3PRGD
2
SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals
. Dose-Response 17:4, pages 155932581988254.
Crossref
Crossref
Li Zhang, Dan Pu, Dan Liu, Ye Wang, Wenxin Luo, Huairong Tang, Yan Huang & Weimin Li. (2019) Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer. Lung Cancer 135, pages 130-137.
Crossref
Crossref
Azadeh Abravan, Hanne Astrid Eide, Ayca Muftuler Løndalen, Åslaug Helland & Eirik Malinen. (2018) Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer. Molecular Imaging and Biology 21:2, pages 391-398.
Crossref
Crossref
Katsuyuki Tanabe, Yasufumi Sato & Jun Wada. (2018) Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression. International Journal of Molecular Sciences 19:7, pages 1859.
Crossref
Crossref
Chen Zhao, Jeffrey S. Isenberg & Aleksander S. Popel. (2018) Human expression patterns: qualitative and quantitative analysis of thrombospondin‐1 under physiological and pathological conditions. Journal of Cellular and Molecular Medicine 22:4, pages 2086-2097.
Crossref
Crossref
Naoyoshi Maeda & Katsumi Maenaka. (2017) The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets. International Journal of Molecular Sciences 18:10, pages 2198.
Crossref
Crossref
M. R. Custead, H.Y. Weng & M. O. Childress. (2017) Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer. Veterinary and Comparative Oncology 15:3, pages 808-819.
Crossref
Crossref
Bryant R. England, Jeremy Sokolove, William H. Robinson, Geoffrey M. Thiele, Apar K. Ganti, Harlan Sayles, Kaleb Michaud, Liron Caplan, Lisa A. Davis, Grant W. Cannon, Brian Sauer, Namrata Singh, E. Blair Solow, Andreas M. Reimold, Gail S. Kerr, Pascale Schwab, Josh F. Baker & Ted R. Mikuls. (2016) Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis. Arthritis & Rheumatology 68:10, pages 2394-2402.
Crossref
Crossref
Johanna L Barclay, Sahar Keshvari, Jonathan P Whitehead & Warrick J Inder. (2016) Development of an enzyme-linked immunosorbent assay for thrombospondin-1 and comparison of human plasma and serum concentrations. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 53:5, pages 606-610.
Crossref
Crossref
Claire Jenkinson, Victoria L. Elliott, Anthony Evans, Lucy Oldfield, Rosalind E. Jenkins, Darragh P. O'Brien, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Evangelia-O Fourkala, Ian J. Jacobs, Usha Menon, Trevor Cox, Fiona Campbell, Stephen P. Pereira, David A. Tuveson, B. Kevin Park, William Greenhalf, Robert Sutton, John F. Timms, John P. Neoptolemos & Eithne Costello. (2016) Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus. Clinical Cancer Research 22:7, pages 1734-1743.
Crossref
Crossref
Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, Oliver Königsbrügge, Silvia Koder, Christoph Zielinski, Ingrid Pabinger & Cihan Ay. (2016) Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS). Clinical Cancer Research 22:1, pages 200-206.
Crossref
Crossref
Chun-Hua Xu, Lan Cao, Ying Wei & Li-Ke Yu. (2015) Serum Cripto-1 as a Clinical Marker for Lung Cancer. The International Journal of Biological Markers 30:4, pages 369-373.
Crossref
Crossref
P. Ferroni, R. Palmirotta, S. Riondino, M. L. De Marchis, A. Nardecchia, V. Formica, F. Guadagni & M. Roselli. (2015) VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients. Thrombosis and Haemostasis 115:1, pages 143-151.
Crossref
Crossref
Qingjie Ma, Kaiyin Min, Ting Wang, Bin Chen, Qiang Wen, Fan Wang, Tiefeng Ji & Shi Gao. (2015) 99mTc-3PRGD2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab. Annals of Nuclear Medicine 29:6, pages 519-527.
Crossref
Crossref
Aaron J. Smith, John Oertle & Dino Prato. (2015) Novel Approach to Chemotherapy and Administration Selection with Metronomic/Fractionated Dosing. Journal of Cancer Therapy 06:05, pages 455-465.
Crossref
Crossref
Jon Cleland, Faisal Azam, Rachel Midgley & David J. Kerr. 2015. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine
185
188
.
Tina El Rayes, Raul Catena, Shahin Rafii, Nasser Altorki & Vivek Mittal. 2015. Inflammation and Lung Cancer. Inflammation and Lung Cancer
137
159
.
Ravi Salgia. (2014) Fibroblast growth factor signaling and inhibition in non‐small cell lung cancer and their role in squamous cell tumors. Cancer Medicine 3:3, pages 681-692.
Crossref
Crossref
Bilal Piperdi, Amartej Merla & Roman Perez-Soler. (2014) Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer. Drugs 74:4, pages 403-413.
Crossref
Crossref
Guanghua Xiao, Shuangge Ma, John Minna & Yang Xie. (2014) Adaptive Prediction Model in Prospective Molecular Signature–Based Clinical Studies. Clinical Cancer Research 20:3, pages 531-539.
Crossref
Crossref
J. Riedl, I. Pabinger & C. Ay. (2017) Platelets in cancer and thrombosis. Hämostaseologie 34:01, pages 54-62.
Crossref
Crossref
T. Fleitas, V. Martínez-Sales, V. Vila, E. Reganon, D. Mesado, M. Martín, J. Gómez-Codina, J. Montalar & G. Reynés. (2013) VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer. Clinical and Translational Oncology 15:11, pages 897-902.
Crossref
Crossref
X.-P. Tang, J. Li, L.-C. Yu, Y.-C. Chen, S.-B. Shi, L.-R. Zhu & P. Chen. (2013) Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery. Lung Cancer 81:2, pages 273-279.
Crossref
Crossref
Pingping Hu, Weidong Liu, Liguang Wang, Miaomiao Yang & Jiajun Du. (2013) High circulating VEGF level predicts poor overall survival in lung cancer. Journal of Cancer Research and Clinical Oncology 139:7, pages 1157-1167.
Crossref
Crossref
Jonathan Golledge, Paula Clancy, Graeme J. Hankey & Paul E. Norman. (2013) Relation Between Serum Thrombospondin-2 and Cardiovascular Mortality in Older Men Screened for Abdominal Aortic Aneurysm. The American Journal of Cardiology 111:12, pages 1800-1804.
Crossref
Crossref
P. W. Kämmerer, F. P. Koch, E. Schiegnitz, V. V. Kumar, M. Berres, T. Toyoshima, B. Al-Nawas & J. Brieger. (2013) Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 42:5, pages 374-381.
Crossref
Crossref
Mohsen Azimi-NezhadDaniel LambertCatherine OttoneCorinne PerrinCeline ChapelGwenaëlle GaillardMichèle PfisterChristine MassonEric TaboneFay BetsouDavid MeyronetMarie-Noëlle UngeheuerSophie Visvikis Siest. (2012) Influence of Pre-analytical Variables on VEGF Gene Expression and Circulating Protein Concentrations. Biopreservation and Biobanking 10:5, pages 454-461.
Crossref
Crossref
Hanna Lee, Meiying Song, Nara Shin, Chang Hoon Shin, Byung Soh Min, Hyon-Suk Kim, Jong Shin Yoo & Hoguen Kim. (2012) Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas. PLoS ONE 7:4, pages e34318.
Crossref
Crossref
William L. Bigbee, Vanathi Gopalakrishnan, Joel L. Weissfeld, David O. Wilson, Sanja Dacic, Anna E. Lokshin & Jill M. Siegfried. (2012) A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening. Journal of Thoracic Oncology 7:4, pages 698-708.
Crossref
Crossref
James P. MaloneyRobert S. Stearman, Todd M. Bull, David W. Calabrese, Megan L. Tripp-Addison, Marilee J. Wick, Ulrich Broeckel, Ivan M. Robbins, Lisa A. Wheeler, Joy D. Cogan & James E. Loyd. (2012) Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:6, pages L541-L554.
Crossref
Crossref
Jill E. Larsen & John D. Minna. (2011) Molecular Biology of Lung Cancer: Clinical Implications. Clinics in Chest Medicine 32:4, pages 703-740.
Crossref
Crossref
Chunxia Su, Caicun Zhou, Songwen Zhou & Jianfang Xu. (2010) Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Medical Oncology 28:4, pages 1453-1457.
Crossref
Crossref
Jill E. Larsen, Tina Cascone, David E. Gerber, John V. Heymach & John D. Minna. (2011) Targeted Therapies for Lung Cancer. The Cancer Journal 17:6, pages 512-527.
Crossref
Crossref
Andriani Charpidou, Ioannis Gkiozos, Marios Konstantinou, Anastasia Eleftheraki, Panagiotis Demertzis, Kevin Harrington, Aris Polyzos & Kostas N. Syrigos. (2011) Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. Cancer Letters 304:2, pages 144-153.
Crossref
Crossref
Qian Qian, Ping Zhan, Like Yu, Yi Shi, Jinfei Cheng, Shuzhen Wei, Qian Wang & Yong Song. (2011) Baseline Levels and Decrease in Serum Soluble Intercellular Adhesion Molecule-1 During Chemotherapy Predict Objective Response and Survival in Patients Who Have Advanced Non?Small-Cell Lung Cancer. Clinical Lung Cancer 12:2, pages 131-137.
Crossref
Crossref
Anja Elstner, Florian Stockhammer, Trong-Nghia Nguyen-Dobinsky, Quang Long Nguyen, Ingo Pilgermann, Amanjit Gill, Anke Guhr, Tingguo Zhang, Kajetan von Eckardstein, Thomas Picht, Julian Veelken, Robert L. Martuza, Andreas von Deimling & Andreas Kurtz. (2010) Identification of diagnostic serum protein profiles of glioblastoma patients. Journal of Neuro-Oncology 102:1, pages 71-80.
Crossref
Crossref
Jin-Hai Tang, Jian-Hua Zhao, Jian-Wei Lu, Feng Yan, Jian-Wei Qin & Bin Xu. (2010) Circulating levels of angiogenic cytokines in advanced breast cancer patients with system chemotherapy and their potential value in monitoring disease course. Journal of Cancer Research and Clinical Oncology 137:1, pages 55-63.
Crossref
Crossref
Peer W. Kämmerer, Takeshi Toyoshima, Sami Eletr, Philipp Kämmerer, Kathrin Kuhr, Bilal Al-Nawas & Jürgen Brieger. (2010) Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 39:10, pages 786-792.
Crossref
Crossref
Haiyan Hu. (2010) Mining patterns in disease classification forests. Journal of Biomedical Informatics 43:5, pages 820-827.
Crossref
Crossref
Alexander Zaslavsky, Kwan-Hyuck Baek, Ryan C. Lynch, Sarah Short, Jenny Grillo, Judah Folkman, Joseph E. ItalianoJrJr & Sandra Ryeom. (2010) Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 115:22, pages 4605-4613.
Crossref
Crossref
Wojciech Naumnik, Wiesława Nilklińska, Maria Ossolińska & Elzbieta Chyczewska. (2010) Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy.. Folia Histochemica et Cytobiologica 47:4.
Crossref
Crossref
Nan Soon WongRobert A. BuckmanMark ClemonsShailendra VermaSusan DentMaureen E. TrudeauKathie RocheJohn EbosRobert KerbelGerrit E. DeBoerDonald J.A. SutherlandUrban EmmeneggerJoyce SlingerlandSandra GardnerKathleen I. Pritchard. (2010) Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response. Journal of Clinical Oncology 28:5, pages 723-730.
Crossref
Crossref
Elias A. Kotteas, Andriani G. Charpidou & Kostas N. Syrigos. (2010) Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors. Anti-Cancer Drugs 21:2, pages 151-168.
Crossref
Crossref
RYUJI IKEDA, LEE C. VERMEULEN, ZHISHENG JIANG, ELIM LAU & JILL M. KOLESAR. (2010) Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells. Experimental and Therapeutic Medicine 1:5, pages 853-857.
Crossref
Crossref
Christopher G. AzzoliSherman BakerJrJrSarah TeminWilliam PaoTimothy AliffJulie BrahmerDavid H. JohnsonJanessa L. LaskinGregory MastersDaniel MiltonLuke NordquistDavid G. PfisterSteven PiantadosiJoan H. SchillerReily SmithThomas J. SmithJohn R. StrawnDavid TrentGiuseppe Giaccone. (2009) American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 27:36, pages 6251-6266.
Crossref
Crossref
Sachin Kumar, Randeep Guleria, Vikas Singh, Alok C Bharti, Anant Mohan & Bhudev C Das. (2009) Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer. BMC Cancer 9:1.
Crossref
Crossref
Katsuhiro Masago, Shiro Fujita, Yung Haku Kim, Yukimasa Hatachi, Akiko Fukuhara, Hiroki Nagai, Kaoru Irisa, Masataka Ichikawa, Tadashi Mio & Michiaki Mishima. (2009) Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. Cancer Science 100:10, pages 1917-1922.
Crossref
Crossref
S. B. Polikarpova, N. V. Lyubimova, E. A. Smirnova, T. A. Britvin, A. S. Ogereliev & M. I. Davidov. (2010) Serum Angiogenic Factors in Patients with Neuroendocrine Tumors of Abdominal Organs. Bulletin of Experimental Biology and Medicine 148:4, pages 634-637.
Crossref
Crossref
Lokesh Jain, Craig A. Vargo, Romano Danesi, Tristan M. Sissung, Douglas K. Price, David Venzon, Jürgen Venitz & William D. Figg. (2009) The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Molecular Cancer Therapeutics 8:9, pages 2496-2508.
Crossref
Crossref
Tomoko Hosaka, Hiroshi Kimura, Takahiro Heishi, Yasuhiro Suzuki, Hiroki Miyashita, Hideki Ohta, Hikaru Sonoda, Takuya Moriya, Satoshi Suzuki, Takashi Kondo & Yasufumi Sato. (2009) Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis. The American Journal of Pathology 175:1, pages 430-439.
Crossref
Crossref
M Waheed Roomi, Nusrath W Roomi, Tatiana Kalinovsky, Matthias Rath & Aleksandra Niedzwiecki. (2018) Chemopreventive Effect of a Novel Nutrient Mixture on Lung Tumorigenesis Induced by Urethane in Male A/J Mice. Tumori Journal 95:4, pages 508-513.
Crossref
Crossref
ZJ Chen, HB Le, YK Zhang, LY Qian & WD Li. (2009) Microvessel Density and Expression of Thrombospondin-1 in Non-small Cell Lung Cancer and Their Correlation with Clinicopathological Features. Journal of International Medical Research 37:2, pages 551-556.
Crossref
Crossref
Simon J. Crabb, Demetris Patsios, Eric Sauerbrei, Peter M. Ellis, Andrew Arnold, Glenwood Goss, Natasha B. Leighl, Frances A. Shepherd, Jean Powers, Lesley Seymour & Scott A. Laurie. (2009) Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 27:3, pages 404-410.
Crossref
Crossref
Mioko Ide, Hiroshi Ishii, Hiroshi Mukae, Atsuko Iwata, Noriho Sakamoto, Jun-ichi Kadota & Shigeru Kohno. (2008) High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia. Respiratory Medicine 102:11, pages 1625-1630.
Crossref
Crossref
Cristiana Pistol-TanaseElena RaducanSimona Olimpia DimaLucian AlbulescuIonita AlinaPoroschianu MariusLinda Maria CruceruEleonora CodoreanTeodora Monica NeaguIrinel Popescu. (2008) Assessment of soluble angiogenic markers in pancreatic cancer. Biomarkers in Medicine 2:5, pages 447-455.
Crossref
Crossref
Mohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, Marie Cecile Bozonnat, Xavier Quantin, William Jacot & Jean-Pierre Daurès. (2008) Circulating Serum Vascular Endothelial Growth Factor is Not a Prognostic Factor of Non-small Cell Lung Cancer. Journal of Thoracic Oncology 3:10, pages 1119-1126.
Crossref
Crossref
Sen YANG, Xiao-yi WANG, Li-juan GUO, Xiu-fa TANG, Qing-hong GAO, Ming XUAN, Qiang ZHANG, Ke TAN, Yu-ming WEN, Chang-mei WANG, Rui-an XU & Yu-tang CAO. (2008) Correlation between the expression of thrombospondin-1 and neovascularization in mucoepidermoid carcinoma. Chinese Medical Journal 121:19, pages 1875-1881.
Crossref
Crossref
Yingcheng Lin, De Zeng, Hongbiao Wang, Wenzhao Lin, Wen Lin & Chaoqun Hong. (2008) Clinical significance of serum vascular endothelial growth factor in advanced malignant tumors. The Chinese-German Journal of Clinical Oncology 7:10, pages 611-614.
Crossref
Crossref
Takashi Muramatsu & Hisako Muramatsu. (2008) Glycosaminoglycan-binding cytokines as tumor markers. PROTEOMICS 8:16, pages 3350-3359.
Crossref
Crossref
Guo-Hua Fong. (2008) Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 11:2, pages 121-140.
Crossref
Crossref
Elif Sen, Fusun Ulger, Akin Kaya, Nejat Akar & Ugur Gonullu. (2008) Serum Endothelial Monocyte-Activating Polypeptide?II: A Novel Biomarker in Patients with Non?Small-Cell Lung Cancer. Clinical Lung Cancer 9:3, pages 166-170.
Crossref
Crossref
Faruk Tas, Derya Duranyildiz, Hilal O. Soydinc, Irfan Cicin, Meltem Selam, Kazim Uygun, Rian Disci, Vildan Yasasever & Erkan Topuz. (2007) Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer. Cancer Chemotherapy and Pharmacology 61:5, pages 721-725.
Crossref
Crossref
Christophe Van de Wiele, Frédéric VandeVyver, Caroline Debruyne, Jan Philippé & Jan P. van Meerbeeck. (2007) FDG uptake by the bone marrow in NSCLC patients is related to TGF-β but not to VEGF or G-CSF serum levels. European Journal of Nuclear Medicine and Molecular Imaging 35:3, pages 519-522.
Crossref
Crossref
Rihong Zhai, Geoffrey Liu, Wei Zhou, Li Su, Rebecca Suk Heist, Thomas J. Lynch, John C. Wain, Kofi Asomaning, Xihong Lin & David C. Christiani. (2008) Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer. Clinical Cancer Research 14:2, pages 612-617.
Crossref
Crossref
S Metodieva. (2008) Angiogenesis and Non Small Cell Lung Cancer. Balkan Journal of Medical Genetics 11:2.
Crossref
Crossref
Eui Jung MoonDavid M. BrizelJen–Tsan Ashley ChiMark W. Dewhirst. (2007) The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer. Antioxidants & Redox Signaling 9:8, pages 1237-1294.
Crossref
Crossref
Joo Hun Park, Kwang Joo Park, Young Sun Kim, Seung Soo Sheen, Keu Sung Lee, Hyoung No Lee, Yoon Jung Oh & Sung Chul Hwang. (2007) Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer. Chest 132:1, pages 200-206.
Crossref
Crossref
Angeles Alvarez Secord, Kathleen M. Darcy, Alan Hutson, Paula S. Lee, Laura J. Havrilesky, Lisa A. Grace & Andrew Berchuck. (2007) Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecologic Oncology 106:1, pages 221-232.
Crossref
Crossref
Andriana I Papaioannou, Konstantinos Kostikas, Panagoula Kollia & Konstantinos I Gourgoulianis. (2006) Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?. Respiratory Research 7:1.
Crossref
Crossref
Mukaddes Colakogullari, Engin Ulukaya, Arzu Yilmaztepe, Gokhan Ocakoglu, Meryem Yilmaz, Mehmet Karadag & Asuman Tokullugil. (2006) Higher serum nitrate levels are associated with poor survival in lung cancer patients. Clinical Biochemistry 39:9, pages 898-903.
Crossref
Crossref
Shigang Ding, Chenggang Li, Sanren Lin, Yu Yang, Donghui Liu, Yajing Han, Ying Zhang, Lina Li, Liya Zhou & Shant Kumar. (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Human Pathology 37:7, pages 861-866.
Crossref
Crossref
Rana P. Singh, Gagan Deep, Manesh Chittezhath, Manjinder Kaur, Lori D. Dwyer-Nield, Alvin M. Malkinson & Rajesh Agarwal. (2006) Effect of Silibinin on the Growth and Progression of Primary Lung Tumors in Mice. JNCI: Journal of the National Cancer Institute 98:12, pages 846-855.
Crossref
Crossref
Carmen I. Calfa, Joseph D. Rosenblatt, Hyun-Mi Cho, Keith Webster & Seung-Uon Shin. (2006) Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents. Update on Cancer Therapeutics 1:2, pages 159-173.
Crossref
Crossref